Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 12, Number 2—February 2006

Synopsis

Bartonella quintana Characteristics and Clinical Management

Cédric Foucault*, Philippe Brouqui*, and Didier Raoult*Comments to Author 
Author affiliations: *Université de la Méditerranée, Marseille, France

Main Article

Figure 4

Western blot and cross-adsorption results in a patient with Bartonella quintana endocarditis. A) Nonadsorbed. B) Adsorbed with B. quintana. C) Adsorbed with B. henselae. Lane 1, B. quintana; lane 2, B. henselae; lane 3, B. elizabethae; lane 4, B. vinsonii subsp. Berkhoffi; lane 5, B. vinsonii subsp. Arupensis. Before adsorption (A), antibodies are detected against all species (1, 2, 3, 4, and 5). After adsorption with B. quintana antigen (B), all antibodies disappear. After adsorption with B. he

Figure 4. Western blot and cross-adsorption results in a patient with Bartonella quintana endocarditis. A) Nonadsorbed. B) Adsorbed with B. quintana. C) Adsorbed with B. henselae. Lane 1, B. quintana; lane 2, B. henselae; lane 3, B. elizabethae; lane 4, B. vinsonii subsp. Berkhoffi; lane 5, B. vinsonii subsp. Arupensis. Before adsorption (A), antibodies are detected against all species (1, 2, 3, 4, and 5). After adsorption with B. quintana antigen (B), all antibodies disappear. After adsorption with B. henselae antigen (C), antibodies against B. quintana (1) persist. This reaction shows B. quintana infection.

Main Article

TOP